Drive Therapeutics is a new biotechnology company that strives to improve treatment for retinal diseases.
Drive Therapeutics has raised $75K in total funding. The most recent round was Grant. The last funding was announced in September 2022.
Drive Therapeutics's investors include National Science Foundation, North Carolina Biotechnology Center, One North Carolina Small Business Program.
Drive Therapeutics is headquartered in Chapel Hill, United States.
Drive Therapeutics is a new biotechnology company that strives to improve treatment for retinal diseases.
Drive Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Drive Therapeutics — Funding & Investors." VCBacked, September 22, 2022, https://www.vcbacked.co/company/drive-therapeutics. Accessed September 30, 2026.
VCBacked. (2022). Drive Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/drive-therapeutics
{{cite web |title=Drive Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/drive-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated